Statins May Increase Type 2 Diabetes Risk
According to EuropeanPharmaceuticalReview.com, researchers concluded a 15-year study on cholesterol-lowering statin medications. In the study, which was published in the British Journal of Clinical Pharmacology, patients who are prescribed statin medications may be “at a higher risk for developing high blood sugar levels, insulin … [Read more...] about Statins May Increase Type 2 Diabetes Risk
Study Sees Diabetes Risk with High-Dose Statins
A new study is providing yet another reason to avoid High-Dose Statins, Zocor. The study, conducted by researchers in the U.K., has found that high doses of statins, including Zocor and its generic equivalent, simvastatin, are associated with an increased risk of diabetes. The same study also found that 80 mg of simvastatin was not … [Read more...] about Study Sees Diabetes Risk with High-Dose Statins
Statins Risky for MS Patients
Statins Risky for MS Patients. Some statins—drugs that lower blood cholesterol levels—have been linked to various adverse events. Now, an emerging study has found that the medications might be negatively affecting patients with Multiple Sclerosis (MS), reports Science Daily, especially in those patients taking high daily doses of … [Read more...] about Statins Risky for MS Patients
Insurers Reassess Vytorin Coverage
Vytorin Provided No Added Benefits. Insurers are said to be reconsidering coverage for Vytorin, after a study showed the cholesterol-lowering drug provided no added benefits over cheaper statins. Already, one large insurer has changed its approach to Vytorin coverage, and it is thought others will follow. Vytorin, which … [Read more...] about Insurers Reassess Vytorin Coverage
Cholesterol Drugs Linked to Parkinson’s
Connection Between Cholesterol Drugs And Parkinson's Disease. A new study published today has suggested a connection between statins (drugs used to lower cholesterol) and the development of Parkinson’s disease. Researchers at the University of North Carolina found that patients with low levels of LDL cholesterol are upward of three … [Read more...] about Cholesterol Drugs Linked to Parkinson’s
Crestor Debate Intensifies
Crestor, The Newest In A Class Of Drugs Known As Statins. The Food and Drug Administration is raising questions about the cholesterol-lowering drug Crestor, the newest in a class of drugs known as statins. The consumer group Public Citizen has long been calling for Crestor's recall, citing a higher risk for a serious muscle … [Read more...] about Crestor Debate Intensifies
Risks Posed By Crestor May Be Worse
Crestor Greater Risks Than Other Statins. The cholesterol-lowering "statin" drug Crestor (manufactured by AstraZeneca) has been the subject of controversy since it was first approved for sale in the United States in August 2003. While consumer groups like Public Citizen and medical experts (including FDA official and whistleblower, … [Read more...] about Risks Posed By Crestor May Be Worse
Statins: A Risk To Your Baby?
Statins May Cause Birth Defects. Some birth-defects specialists say they are concerned about the possibility of a cholesterol-lowering statin drug going over the counter, a move to be considered today and Friday by a Food and Drug Administration advisory committee. In a joint venture with Johnson & Johnson, drugmaker Merck has … [Read more...] about Statins: A Risk To Your Baby?
